KENACORT Drug Patent Profile

Which patents cover Kenacort, and when can generic versions of Kenacort launch?

Kenacort is a drug marketed by Delcor Asset Corp and is included in two NDAs.

The generic ingredient in KENACORT is triamcinolone. There are fifty-one drug master file entries for this compound. Additional details are available on the triamcinolone profile page.

Summary for KENACORT

US Patents:	0
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	76
Clinical Trials:	12
Formulation / Manufacturing:	see details
DailyMed Link:	KENACORT at DailyMed

Recent Clinical Trials for KENACORT

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Sohag University	Phase 4
Assiut University	Phase 4
Kessler Foundation	Phase 2

See all KENACORT clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for KENACORT

A01AC	Corticosteroids for local oral treatment
A01A	STOMATOLOGICAL PREPARATIONS
A01	STOMATOLOGICAL PREPARATIONS
A	Alimentary tract and metabolism

C05AA	Corticosteroids
C05A	AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
C05	VASOPROTECTIVES
C	Cardiovascular system

D07AB	Corticosteroids, moderately potent (group II)
D07A	CORTICOSTEROIDS, PLAIN
D07	CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D	Dermatologicals

D07XB	Corticosteroids, moderately potent, other combinations
D07X	CORTICOSTEROIDS, OTHER COMBINATIONS
D07	CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D	Dermatologicals

H02AB	Glucocorticoids
H02A	CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
H02	CORTICOSTEROIDS FOR SYSTEMIC USE
H	Systemic hormonal preparations, excluding sex hormones and insulins

R01AD	Corticosteroids
R01A	DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01	NASAL PREPARATIONS
R	Respiratory system

R03BA	Glucocorticoids
R03B	OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
R03	DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R	Respiratory system

S01BA	Corticosteroids, plain
S01B	ANTIINFLAMMATORY AGENTS
S01	OPHTHALMOLOGICALS
S	Sensory organs

US Patents and Regulatory Information for KENACORT

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Delcor Asset Corp	KENACORT	triamcinolone diacetate	SYRUP;ORAL	012515-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Delcor Asset Corp	KENACORT	triamcinolone	TABLET;ORAL	011283-006	Approved Prior to Jan 1, 1982		DISCN	No	No
Delcor Asset Corp	KENACORT	triamcinolone	TABLET;ORAL	011283-003	Approved Prior to Jan 1, 1982		DISCN	No	No
Delcor Asset Corp	KENACORT	triamcinolone	TABLET;ORAL	011283-008	Approved Prior to Jan 1, 1982		DISCN	No	No
Delcor Asset Corp	KENACORT	triamcinolone	TABLET;ORAL	011283-010	Approved Prior to Jan 1, 1982		DISCN	No	No